Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **polymeric immunoglobulin receptor** (pIgR) is a transmembrane glycoprotein expressed predominantly on the basolateral surface of epithelial cells lining mucosal surfaces. It belongs to the immunoglobulin superfamily and functions as an Fc receptor specialized for binding polymeric forms of immunoglobulins—specifically dimeric IgA and pentameric IgM—produced by local plasma cells in subepithelial tissues. Upon binding these antibodies via their J-chain, pIgR mediates their transcytosis from the basolateral side through epithelial cells to the apical surface. There, proteolytic cleavage releases its extracellular domain—the "secretory component"—either free or complexed with antibody into mucus secretions. This process results in formation of **secretory IgA** (SIgA) and **secretory IgM** (SIgM), which play critical roles in immune defense by neutralizing pathogens at mucosal barriers without triggering inflammation. The secretory component also protects these antibodies from proteolytic degradation within harsh luminal environments and can itself bind bacteria non-specifically, contributing further to host defense. Genetic variation in PIGR has been associated with diseases such as **IgA nephropathy**, while deficiency impairs secretion of SIgA/SIgM leading to increased risk for infections at mucosal sites. The magnitude of pIgR-mediated transport is highest in intestinal epithelium but occurs throughout various glandular tissues including respiratory tract, mammary glands, liver bile ducts, etc.[1][3][4][6]
Not applicable; there are no approved drugs that act directly on this receptor. Its function is primarily physiological—mediating antibody transport and immune exclusion.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polymeric immunoglobulin receptor (pIgR).